➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Johnson and Johnson
Harvard Business School
Express Scripts
Moodys

Last Updated: July 13, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Molidustat


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Molidustat?

Molidustat is an investigational drug.

There have been 9 clinical trials for Molidustat. The most recent clinical trial was a Phase 2 trial, which was initiated on February 22nd 2018.

The most common disease conditions in clinical trials are Renal Insufficiency, Chronic, Renal Insufficiency, and Anemia. The leading clinical trial sponsors are Bayer and [disabled in preview].

There are eight US patents protecting this investigational drug and one hundred and eighty-six international patents.

Recent Clinical Trials for Molidustat
TitleSponsorPhase
Maintenance Treatment of Renal Anemia in Dialysis SubjectsBayerPhase 3
A Study of Molidustat for Treatment of Renal Anemia in Peritoneal Dialysis SubjectsBayerPhase 3
A Study of Molidustat for Correction of Renal Anemia in Dialysis SubjectsBayerPhase 3

See all Molidustat clinical trials

Clinical Trial Summary for Molidustat

Top disease conditions for Molidustat
Top clinical trial sponsors for Molidustat

See all Molidustat clinical trials

US Patents for Molidustat

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Molidustat   Start Trial Method for the preparation of triazole compounds BAYER PHARMA AKTIENGESELLSCHAFT (Berlin, DE)   Start Trial
Molidustat   Start Trial Substituted dihydropyrazolones for treating cardiovascular and hematological diseases Bayer Intellectual Property GmbH (Monheim, DE)   Start Trial
Molidustat   Start Trial Substituted sodium 1H-pyrazol-5-olate Bayer Intellectual Property GmbH (Monheim, DE)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Moodys
Baxter
Johnson and Johnson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.